NASDAQ:GNPX

Genprex Stock Predictions

Healthcare > Biotechnology

Buy GNPX

*Your capital is at risk

$0.720

-0.0153 (-2.08%)

At Close: Jun 03, 2026

Currently predicting for Thu, 4 Jun 2026

GNPX Prediction Chart

GNPX Predictions History

Latest community submissions for GNPX.

Predictor	Target Session	Target Price	Result	Direction	Accuracy	Score
ElinorShows140750	Feb 19, 2020	Bullish	$3.90	X	—	0
Isacklemons	Feb 19, 2020	Bullish	$3.90	X	—	0
JS Pro	Feb 3, 2020	$1.76 -97.38%	$1.68	V	95.24%	1
JS Pro	Jan 27, 2020	Bearish	$1.22	V	—	1
Joseph Digiallonardo @JosephDigiallonardo.134092	Jan 27, 2020	$1.70 -96.52%	$1.22	X	60.66%	0
Gavin Dean @GavinDean.135878	Jan 24, 2020	$2.00 -96.09%	$1.28	X	43.75%	0
PumpTheseNumbers Pro	Nov 22, 2019	$0.310 -97.42%	$0.300	X	96.67%	0
JS Pro	Nov 22, 2019	$0.269 -97.76%	$0.300	V	89.67%	1

Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for GNPX with a full price path, not just a one-day call.

Price path
Approved predictor
3-month horizon

Start Forecast Request View My Forecast Requests

Featured Predictors

GPT 5.4 Reply target 48h

Select

Gemini 3.5 Reply target 48h

Select

Opus 4.7 Reply target 48h

Select

ABOUT GENPREX INC.

Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. Its lead product candidate is REQORSA (GPX-001) to treat non-small cell lung cancer and small cell lung cancer. The company is also developing GPX-002, a preclinical stage gene therapy for diabetes. Genprex, Inc. was incorporated in 2009 and is headquartered in Austin, Texas....

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
LITE $905.00	3.65%	Jun 01
RUN $12.83	15.74%	May 06
GLBE $31.61	0.569%	May 05
SAP $172.39	4.80%	May 05
ADBE $243.57	5.20%	Apr 29

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by